Safety and Efficacy of Chloroquine and Primaquine for Vivax Malaria in Bhutan
Status:
Completed
Trial end date:
2015-10-01
Target enrollment:
Participant gender:
Summary
This research is intended to study the efficacy of chloroquine (CQ) and primaquine (PQ) for
Plasmodium vivax (P.vivax) infection, and also to study the recurrence rate among patients
with P.vivax malaria on standard doses of CQ and PQ. For this study, PQ will be withheld for
28 days so as to study the efficacy of CQ alone.
This study will assess whether CQ is still effective against P.vivax or whether there are
resistant P.vivax strains in Bhutan.